Validity of World Health Organisation prescribing indicators in Namibia's primary healthcare: findings and implications.


Journal

International journal for quality in health care : journal of the International Society for Quality in Health Care
ISSN: 1464-3677
Titre abrégé: Int J Qual Health Care
Pays: England
ID NLM: 9434628

Informations de publication

Date de publication:
01 Jun 2019
Historique:
received: 06 02 2017
revised: 03 06 2018
accepted: 26 07 2018
pubmed: 1 9 2018
medline: 23 10 2019
entrez: 1 9 2018
Statut: ppublish

Résumé

World Health Organization/International Network of Rational use of Drugs (WHO/INRUD) indicators are widely used to assess medicine use. However, there is limited evidence on their validity in Namibia's primary health care (PHC) to assess the quality of prescribing. Consequently, our aim was to address this. An analytical cross-sectional survey design was used to examine and validate WHO/INRUD indicators in out-patient units of two PHC facilities and one hospital in Namibia from 1 February 2015 to 31 July 2015. The validity of the indicators was determined using two-by-two tables against compliance to the Namibian standard treatment guidelines (NSTG). The receiver operator characteristics for the WHO/INRUD indicators were plotted to determine their accuracy as predictors of compliance to agreed standards. A multivariate logistic model was constructed to independently determine the prediction of each indicator. Out of 1243 prescriptions; compliance to NSTG prescribing in ambulatory care was sub-optimal (target was >80%). Three of the four WHO/INRUD indicators did not meet Namibian or WHO targets: antibiotic prescribing, average number of medicines per prescription and generic prescribing. The majority of the indicators had low sensitivity and/or specificity. All WHO/INRUD indicators had poor accuracy in predicting rational prescribing. The antibiotic prescribing indicator was the only covariate that was a significant independent risk factor for compliance to NSTGs. WHO/INRUD indicators showed poor accuracy in assessing prescribing practices in ambulatory care in Namibia. There is need for appropriate models and/or criteria to optimize medicine use in ambulatory care in the future.

Identifiants

pubmed: 30169688
pii: 5085497
doi: 10.1093/intqhc/mzy172
doi:

Substances chimiques

Anti-Bacterial Agents 0
Drugs, Generic 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

338-345

Informations de copyright

© The Author(s) 2018. Published by Oxford University Press in association with the International Society for Quality in Health Care. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Q Niaz (Q)

Department of Pharmacy Practice and Policy, Faculty of Health Sciences, University of Namibia, Windhoek, Namibia.

B Godman (B)

Division of Clinical Pharmacology, Karolinska Institute, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom.
Department of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Ga-Rankuwa, Pretoria, South Africa.

A Massele (A)

Department of Biomedical Sciences, Faculty of Medicine, University of Botswana, Gaborone, Botswana.

S Campbell (S)

Centre for Primary Care, Division of Population Health, Health Services Research and Primary Care, University of Manchester, Manchester, UK.
NIHR Greater Manchester Primary Care Patient Safety Translational Research Centre, Institute of Population Health. University of Manchester, Manchester.

A Kurdi (A)

Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom.
Department of Pharmacology, College of Pharmacy, Hawler Medical University, Erbil, Iraq.

H R Kagoya (HR)

Monotiring and Evaluation Unit, Management Sciences for Health, Windhoek-Namibia.

D Kibuule (D)

Department of Pharmacy Practice and Policy, Faculty of Health Sciences, University of Namibia, Windhoek, Namibia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH